Patrick Griffin (@patrick_griffN) header
Patrick Griffin (@patrick_griffN) profile picture

Postdoc @ Harvard HSCRB and the Broad Institute.

Boston, MA
Joined July 2012
Photo by Patrick Griffin (@patrick_griffN)Photo by Patrick Griffin (@patrick_griffN)Photo by Patrick Griffin (@patrick_griffN)Photo by Patrick Griffin (@patrick_griffN)Photo by Patrick Griffin (@patrick_griffN)Photo by Patrick Griffin (@patrick_griffN)Photo by Patrick Griffin (@patrick_griffN)Photo by Patrick Griffin (@patrick_griffN)Photo by Patrick Griffin (@patrick_griffN)
Patrick Griffin retweeted
Help! I need philanthropists to help Impetus Grants produce the missing data AI needs to ACTUALLY cure diseases of aging. There’s a lot of talk about simulation solving biology. Useful simulations don’t come out of thin air: DeepMind’s latest weather prediction model was trained on weather records dating back to 1959. AlphaFold had decades of PDB. Tesla and Waymo’s driving simulations draw on data collected over tens of millions of miles on real roads. Building the biological equivalent requires a much stronger data foundation. We need more observations of how diseases with long timelines like Alzheimer’s unfold and respond to treatments. Some of those observations will take years no matter how fast intelligence improves. So I’m directing @impetusgrants to identify longitudinal biosamples we can use for AI-quality data generation, as well as starting necessary new cohorts today. I started @impetusgrants in 2021 after hearing @patrickc talk about Fast Grants at a conference. If fast grants worked for COVID, why not longevity? COVID was obviously urgent. But far more people die from age-related diseases. Since then we’ve deployed $34M across 146 projects and supported five clinical trials, with resulting publications 100x representation in Nature/Science/Cell About 60% of the papers we assessed had no National Institute on Aging support identified. Very satisfying to see work we funded a few years ago now bearing fruit: norn.group/impetus-grants The next round will fund around 50 projects generating open source data on how diseases of aging develop and respond to treatments. We’ve raised >$9M toward the $15M we need to kick off. If you’d like to help fund this or know someone who could, please DM me. (No fancy video of rockets and art deco, all our money goes to longevity research)
9
41
8
92
7,262
Patrick Griffin retweeted
Our paper is out in @NatureAging. We looked for factors that make old cells' gene expression young without erasing their identity. SRSF1 came out as a promising rejuvenation target that reduced aging hallmarks in human cells and extended median lifespan of aged mice by 14%. 1/4
8
40
6
132
7,271
Patrick Griffin retweeted
Today we announced interim data from our first-in-human, Phase 1 clinical trial evaluating our lead program in optic neuropathies, showing it was well-tolerated by 3 participants with glaucoma. Read more about our safety & visual field observations here:bit.ly/4ASWq0p
24
96
38
560
78,024
Patrick Griffin retweeted
1/ Excited to share our new preprint from a joint collaboration between @JswLab + @Bruce_Ksander! Aging is marked by a progressive loss of resilience to stress. Can we systematically search the human ORFome for genes that make vulnerable cells more resilient? Performing such a genome-scale ORF screen led us to NKX2-5—a heart transcription factor we engineered to restore vision, and improve health in aged mice. A breakdown🧵 🔗 doi.org/10.64898/2026.09.29.…
14
50
8
239
51,903
Patrick Griffin retweeted
Infinite Epigenetics & True Diagnostics acquire @sinclairfriends lab spin-out, Tally, giving them access to DNAme IP to help bring down costs & accelerate epigenetics-informed health care Congrats to @L_Catterton, @melanie_goldey, @patrick_griffN, @gladyshev_lab & the entire team! 👏
10
25
2
227
28,092
Patrick Griffin retweeted
It takes two (transcription factors) to tango Transcription factor collaboration enables precise T cell state engineering tinyurl.com/tcelltfs Excited to share our preprint with @JD_Buenrostro, @cgersbach, and an incredible team of collaborators as part of @IGVFConsortium 🧵
2
61
5
223
30,560
Patrick Griffin retweeted
Excited to share my postdoc work with @JD_Buenrostro now out in @Nature! "Epigenetic memory of colitis promotes tumour growth" nature.com/articles/s41586-0… We wanted to understand how transient inflammation can create a long-lived increase in cancer risk, even after full recovery 🧵
11
78
10
369
68,394
Patrick Griffin retweeted
First test of partial epigenetic reprogramming to reverse aging for two eye conditions (glaucoma and NAION) gets FDA go ahead @lifebiosciences Based on 2020 @Nature paper pubmed.ncbi.nlm.nih.gov/3326… endpoints.news/exclusive-fda…
18
187
15
792
59,405
Patrick Griffin retweeted
Huge thanks to all co-authors and the inimitable @JD_Buenrostro for supporting this new direction - I got to think about evolution, engineering, chromatin biophysics, and modeling during the course of this project. For more, check out the preprint: biorxiv.org/content/10.1101/…
1
7
49
3,430
Patrick Griffin retweeted
Excited to share a short article I wrote describing: Slide-tags - which enables spatial single-nucleus sequencing, allowing us to dive deeper into the complexity of tissue organization. Grateful for the amazing team and support from @insitubiology and @macosko! #ToolsOfTheTrade
7
41
6,191
Patrick Griffin retweeted
The latest LLLM (large language of life) foundation model, with state-of-the art chronological age estimation, prediction of outcomes, and performance across different datasets and conditions
Excited to share CpGPT, a new foundation model for DNA methylation, crafted to understand the 'language' of epigenetics! 🧬🤖 What’s CpGPT? CpGPT is a transformer model pre-trained on CpGCorpus, a huge dataset of public DNA methylation info. By integrating sequence, positional, and epigenetic data, it captures complex epigenetic interactions from even a small part of the methylome. 📄 Preprint: biorxiv.org/cgi/content/shor… Why CpGPT? DNA methylation is key for gene expression and chromatin structuring, with CpG sites often varying in diseases like cancer and aging. Here’s what sets CpGPT apart: ✨ CpGPT Highlights: 🔧 Deep Pretraining: Trained on over 100K samples from 1,500+ studies, covering 1M+ CpG sites. 🗺️ Zero-Shot Skills: CpGPT imputes methylation from minimal data, mapping different Illumina arrays to a common reference. 🐭 Cross-Mammalian Reach: When fine-tuned, CpGPT accurately imputes methylation in new mammalian species. 📈 Strong Performance: Fine-tuned CpGPT ranks 2nd overall and 1st on the public leaderboard for age and mortality prediction in the Biomarkers of Aging Challenge. Special shoutout to Lucas (@ollimacsacul) for his outstanding leadership on this project! Big thanks as well to all the co-authors (@rv_sehgal, @prof_horvath, etc.) for their dedication and swift feedback throughout. We're committed to open science and are actively preparing the code. Expect the full code and model weights to be available soon—likely within the next few weeks!
41
3
132
46,951
Patrick Griffin retweeted
Introducing IN SITU GENOME SEQUENCING, a new technology to resolve DNA sequence🧬 and structure🔬 A team effort with @Andrew_C_Payne, @PaulReginato, @eboyden3, @JD_Buenrostro, and Fei Chen science.sciencemag.org/conte… This is how it works: (1/8)
12
528
117
1,309
Thrilled to see our ExIGS tool featured! A true testament to the power of collaboration. Huge congrats to the team for their hard work! 🧬@ajaylabade31 @z_chiang @CarolineComenho nature.com/articles/d41586-0…
1
27
1
116
11,538
Patrick Griffin retweeted
T cells become exhausted and fail to control tumors in cancer patients. What if we could replicate T cell exhaustion in vitro and uncover the gene regulatory network driving exhaustion, enabling immuno-oncology drug discovery? With AstraZeneca, the Buenrostro lab addresses this gap (biorxiv.org/content/10.1101/…):
1
37
1
131
21,435
Study Proposes Framework to Standardize Biomarkers of Aging and Accelerate Clinical Use @jpoganik Read more: buff.ly/3OMHMBo
1
3
3
777
We are recruiting postdoctoral fellows in neurobiology and development to complement our group specializing in genomic technologies, epigenetics and machine learning. projects are very well funded and we are interested in co-mentorship. Please DM if interested in hearing more!
3
51
3
116
36,767
Our latest paper is out - a new method called "TIME-Seq" to measure biological age for just a few dollars. Great work Patrick Griffin! @NatureAging Free download rdcu.be/dvDfc
30
140
12
780
93,811
Patrick Griffin retweeted
Can we reverse aging? 7 yrs ago, Ocampo et al. showed that partial reprogramming can ameliorate aging hallmarks. But, OSKM induction has safety limitations & no new factors have emerged since. Here, biorxiv.org/content/10.1101/… we used 🧬 screens to find new rejuvenation factors🧵1/8
8
72
21
161
49,210
Patrick Griffin retweeted
Delving into our newly released result, a thread:
Sustained Vision Recovery by OSK Gene Therapy in a Mouse Model of Glaucoma: A year-long functional tracking of in vivo partial reprogramming demonstrates safety and efficacy. Work from @margaretekarg @YuanchengLu @davidasinclair @bruce_ksander liebertpub.com/doi/10.1089/c…
11
19
4
106
90,098